Literature DB >> 3311584

Viral infection of the lower respiratory tract.

R M Rose1, P Pinkston, C O'Donnell, W A Jensen.   

Abstract

This article describes the epidemiology, transmission, and pathophysiology of viral infection of the lower respiratory tract. Current approaches to diagnosis, treatment, and prevention also are discussed.

Entities:  

Mesh：

Year:  1987        PMID： 3311584

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  6 in total

Review 1.  Nebulised hypertonic saline solution for acute bronchiolitis in infants.

Authors:  Linjie Zhang; Raúl A Mendoza-Sassi; Claire Wainwright; Terry P Klassen
Journal:  Cochrane Database Syst Rev       Date:  2017-12-21

Review 2.  Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses.

Authors:  Sabhiya Majid; Rabia Farooq; Mosin S Khan; Samia Rashid; Showkat A Bhat; Hilal A Wani; Waseem Qureshi
Journal:  SN Compr Clin Med       Date:  2020-08-25

3.  Two different dosages of ciprofloxacin in patients with respiratory tract infections.

Authors:  T Brutel de la Rivière; M S Daniëls-Bosman; G P ten Velde
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

4.  Risk factors associated with mortality from pneumonia among patients with pneumoconiosis.

Authors:  Bum Seak Jo; Jongin Lee; YounMo Cho; Junsu Byun; Hyoung Ryoul Kim; Jung Wan Koo; Jun Pyo Myong
Journal:  Ann Occup Environ Med       Date:  2016-04-07

5.  Risk factors for community-acquired pneumonia among adults in Kenya: a case-control study.

Authors:  Esther Muthumbi; Brett S Lowe; Cyprian Muyodi; Esther Getambu; Fergus Gleeson; J Anthony G Scott
Journal:  Pneumonia (Nathan)       Date:  2017-11-25

6.  Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials.

Authors:  Chia-Wen Hsieh; Chiehfeng Chen; Hui-Chuan Su; Kee-Hsin Chen
Journal:  BMC Pediatr       Date:  2020-09-14       Impact factor: 2.125
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.